Research & Development
30 March 2023 - Germany-based pharmaceutical company Boehringer Ingelheim reported on Wednesday a strong performance in 2022.The company stated that 2022 was a year in which 30 million patients benefi...
30 March 2023 - Point of care molecular diagnostics company Genedrive plc (AIM:GDR) announced on Thursday that its Genedrive MT-RNR1 ID Kit has received a positive final recommendation from the UK...
29 March 2023 - Biotechnology company Regeneron Pharmaceuticals (NASDAQ:REGN) said on Wednesday that the European Commission has approved Libtayo (cemiplimab) in combination with platinum-based chemot...
29 March 2023 - Biopharmaceutical company Transcenta Holding Limited (Transcenta) (HKEX:06628), a provider of antibody-based therapeutics, reported on Wednesday that the US Food and Drug Administratio...
29 March 2023 - SciBase Holding AB (SciBase) (STO:SCIB), a developer of augmented intelligence-based solutions for skin disorders, revealed on Wednesday that it has entered into a collaboration agreem...
29 March 2023 - Astellas Pharma Inc. (TSE:4503), a Japan-based pharmaceutical company, announced on Tuesday that it has signed an agreement with Roche Diabetes Care Japan Co., Ltd., a global company i...